- Home
- Equipment
- north america
- heparin coating
Refine by
Heparin Coating Equipment Supplied In North America
5 equipment items found
Manufactured by:Artivion, Inc based inKennesaw, GEORGIA (US) (USA)
The FlowLine Bipore HEPARIN vascular grafts are characterized by excellent suture behavior and pliable handling. The grafts are available in thin-wall and standard-wall versions. An additional ePTFE wrap guarantees enhanced suture retention and high burst strength. The innovative heparin coating, in combination with the bipore structure of the ...
by:RAM Scientific, Inc. based inNashville, TENNESSEE (USA)
Designed with the same capillary action properties as glass, our micro hematocrit tubes fill quickly without the risk of breakage. The tubes are available plain or heparinized and are color-coded for easy identification. A red band indicates heparinization; blue indicates plain. Heparinized tubes are evenly coated with either ...
Manufactured by:Surmodics, Inc. based inEden Prairie, MINNESOTA (USA)
The exceptional performance of Surmodics active (heparin) and passive (non-heparin) hemocompatible coatings begins with our proprietary PhotoLink™ UV curing process, which uses light-activated chemistry to bond coatings quickly and evenly to nearly all medical-grade materials. Our rigorous testing and extensive experience ...
Manufactured by:Cardival Medical, Inc. based inSanta Clara, CALIFORNIA (USA)
Studies Have Demonstrated a Reduction in Time to Hemostasis and Ambulation When Compared to Manual Compression. CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients requiring manual compression – helping to reduce mean hold time by over 50% and reduce time to ambulation by more than 20% as compared to manual ...
Manufactured by:LivaNova PLC based inHouston, TEXAS (USA)
Three Components, One Integrated Solution for Acute Respiratory Failure. The HEMOLUNG is the world’s first and only fully-integrated, FDA cleared system for extracorporeal CO2 removal (ECCO2R). The HEMOLUNG removes carbon dioxide directly from the blood at blood flow rates between 350 – 550 mL/min which can mitigate the harmful effects of hypercapnia, respiratory acidosis, intubation ...